GO:0033691 sialic acid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033691 (sialic acid binding) is a molecular function defined as binding to a sialic acid, a nine-carbon monosaccharide derivative of neuraminic acid.
• Siglecs (sialic acid-binding immunoglobulin-like lectins) are the major sialic acid-binding receptor family in the immune system and regulate immune cell function in health and disease.
• Sialic acid binding is exploited by pathogens: viruses, bacteria, and protozoan parasites use sialic acid-binding proteins for host attachment and invasion.
• Siglecs can signal through immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and have non-canonical roles beyond sialic acid binding and immune modulation.
• Sialic acid modifications and identity modulate host tropism and infection outcomes, making sialic acid binding a key research target.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of sialic acid-binding proteins in immunity, infection, and disease.
Description
Sialic acid binding (GO:0033691) is a molecular function that mediates the recognition of sialic acids, a family of nine-carbon monosaccharides typically found at the terminal positions of glycoproteins and glycolipids on cell surfaces. This binding activity is central to many biological processes, including immune cell regulation, host-pathogen interactions, and cell-cell communication. The most well-characterized sialic acid-binding proteins are the Siglecs, a family of immunoglobulin-like lectins expressed on immune cells that translate sialic acid recognition into intracellular signals. Beyond Siglecs, sialic acid-binding proteins are found in viruses, bacteria, and parasites, where they facilitate attachment and entry into host cells. Understanding the molecular basis of sialic acid binding is therefore critical for immunology, microbiology, and therapeutic development. Researchers study this function to uncover how sialic acid recognition shapes immune responses, how pathogens exploit it for infection, and how it can be targeted in disease.
sialic acid binding At A Glance
| GO ID | GO:0033691 |
|---|---|
| GO term | sialic acid binding |
| Ontology | molecular_function |
| Synonym | N-acetylneuraminic acid binding |
| Definition | Binding to a sialic acid, a N- or O- substituted derivative of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria. |
| Major function | Recognition of sialic acid residues on glycoconjugates, mediating immune regulation, pathogen attachment, and cell signaling. |
| Major protein families | Siglecs (sialic acid-binding immunoglobulin-like lectins), viral hemagglutinins, bacterial adhesins, and parasite sialic acid-binding proteins. |
| Disease relevance | Autoimmunity, cancer, neurodegeneration, and infectious diseases. |
| Research methods | CRISPR knockout/knock-in, glycan arrays, surface plasmon resonance, flow cytometry, and structural biology. |
What Is GO:0033691?
GO:0033691 (sialic acid binding) is defined as the binding to a sialic acid, which is an N- or O-substituted derivative of neuraminic acid, a nine-carbon monosaccharide. Sialic acids commonly occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria. This molecular function is often mediated by protein domains that recognize the carboxylate, hydroxyl, and N-acetyl groups of sialic acid, such as the V-set immunoglobulin domain of Siglecs.
Why Is sialic acid binding Important in Cell Biology?
Sialic acid binding is a fundamental recognition event that bridges glycobiology and immunology. It governs how immune cells distinguish self from non-self, how pathogens initiate infection, and how cells communicate. Dysregulation of sialic acid-binding proteins is implicated in autoimmune diseases, cancer progression, and neurodegenerative disorders. Moreover, sialic acid-binding proteins are attractive therapeutic targets and diagnostic markers, and their study informs vaccine design and antiviral strategies.
• Regulates immune cell activation and inhibition through Siglec receptors.
• Mediates host-pathogen interactions for viruses, bacteria, and parasites.
• Involved in cancer immune evasion and tumor progression.
• Contributes to neuroinflammation and neurodegeneration.
• Serves as a target for therapeutic antibodies and inhibitors.
• Guides vaccine design by defining pathogen attachment mechanisms.
• Enables development of glycan-based diagnostics.
• Provides a model for studying protein-carbohydrate recognition.
Molecular Mechanism of sialic acid binding
Sialic Acid Recognition by Siglecs
In simple terms: Siglecs are immune cell receptors that grab onto sialic acids on other cells or molecules.
Siglecs (sialic acid-binding immunoglobulin-like lectins) are type I membrane proteins with an N-terminal V-set immunoglobulin domain that binds sialic acid. The binding specificity varies among Siglec family members, with some preferring alpha-2,3-linked and others alpha-2,6-linked sialic acids. This recognition is critical for immune cell signaling and self-recognition.
Structural Basis of Sialic Acid Binding
In simple terms: The shape of the binding pocket determines which sialic acid it can hold.
The sialic acid-binding site of Siglec-7 has been structurally characterized, revealing key residues that interact with the N-acetylneuraminic acid moiety. The V-set domain forms a hydrophobic pocket and hydrogen bonds with the carboxylate and hydroxyl groups of sialic acid. This structural knowledge informs the design of specific inhibitors and probes.
Pathogen Exploitation of Sialic Acid Binding
In simple terms: Many germs use sialic acid binding to latch onto our cells and start an infection.
Viruses such as influenza and coronaviruses use hemagglutinin or spike proteins to bind sialic acids on host cells. Bacteria like viridans group streptococci bind sialic acids with adhesins, and the identity of sialic acid modulates host tropism. The protozoan parasite Toxoplasma gondii uses a sialic acid-binding protein, SABP1, to attach to and invade host cells.
Signaling and Non-Canonical Roles
In simple terms: Sialic acid binding can trigger signals inside cells, and some Siglecs do more than just bind sialic acid.
Many Siglecs contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit phosphatases to dampen immune activation. However, non-canonical roles of Siglecs, including sialic acid-independent functions, have been described, expanding their functional repertoire. These signaling pathways are actively studied in autoimmunity and cancer.
Regulation of Sialic Acid Binding
In simple terms: Cells can control how much sialic acid they display and how strongly receptors bind it.
Sialic acid binding is regulated by the expression levels of sialic acid-binding proteins and by the density and type of sialic acids on cell surfaces. Sialyltransferases and sialidases modulate the glycan landscape, thereby influencing binding avidity. Additionally, cis-interactions between Siglecs and sialic acids on the same cell can mask binding sites and regulate signaling.
Key Genes Involved in GO:0033691 sialic acid binding
The following genes encode proteins that directly mediate or regulate sialic acid binding (GO:0033691), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SIGLEC1 | Sialoadhesin, binds sialic acids on immune cells | Macrophage-mediated immune regulation |
| SIGLEC7 | Inhibitory Siglec on NK cells and monocytes | Structural studies of sialic acid binding |
| SIGLEC9 | Inhibitory Siglec on neutrophils and eosinophils | Airway inflammation and asthma |
| SIGLEC10 | Inhibitory Siglec on macrophages | Cancer immune evasion |
| SIGLEC15 | Inhibitory Siglec on macrophages and osteoclasts | Cancer immunotherapy target |
| CD22 (SIGLEC2) | Inhibitory Siglec on B cells | Autoimmunity and B cell signaling |
| MAG (SIGLEC4) | Sialic acid-binding lectin in myelin | Neurodegeneration and axon regeneration |
| SIGLEC5 | Inhibitory Siglec on myeloid cells | Inflammation and infection |
| SIGLEC8 | Inhibitory Siglec on eosinophils and mast cells | Allergy and asthma |
| SIGLEC11 | Sialic acid-binding lectin on microglia | Neuroinflammation |
| SIGLEC16 | Siglec-like protein with potential sialic acid binding | Immune regulation |
| SABP1 | Toxoplasma gondii sialic acid-binding protein | Host cell attachment and invasion |
| HA | Influenza hemagglutinin binds sialic acids | Viral entry and host tropism |
| S | Coronavirus spike protein binds sialic acids | Viral attachment and tropism |
| NanA | Bacterial sialidase modulates sialic acid display | Streptococcal infection |
| ST3GAL4 | Sialyltransferase adds alpha-2,3-linked sialic acid | Glycan remodeling and infection |
| NEU1 | Sialidase removes sialic acid from glycoconjugates | Lysosomal storage and immune regulation |
How Is sialic acid binding Regulated?
Sialic acid binding is regulated at multiple levels. The expression of sialic acid-binding proteins such as Siglecs is controlled by transcription factors and cytokines during immune activation. The availability of sialic acid ligands is regulated by sialyltransferases and sialidases, which add or remove sialic acids on glycoproteins and glycolipids. Additionally, cis-interactions between Siglecs and sialic acids on the same cell membrane can mask binding sites and modulate signaling. Pathogens can also regulate sialic acid binding by expressing adhesins with varying affinities in response to host sialic acid identity.
sialic acid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SIGLEC10 | Cancer immune evasion | Knockout in macrophage cell lines; syngeneic tumor models |
| CD22 | Autoimmunity (SLE, IBD) | Knockout mice; B cell signaling assays |
| SIGLEC15 | Cancer immunotherapy target | Knockout in osteoclasts; tumor co-culture |
| MAG | Neurodegeneration (MS, Alzheimer's) | Knockout mice; neuron-glia co-cultures |
| SABP1 | Toxoplasmosis | Parasite knockout; host cell invasion assays |
Sialic Acid Binding in Autoimmunity
Siglec-mediated sialic acid binding is crucial for maintaining immune tolerance. Dysregulation of inhibitory Siglecs such as CD22 and Siglec-10 is associated with autoimmune diseases, including systemic lupus erythematosus and inflammatory bowel disease. Targeting these pathways with sialic acid mimetics or antibodies is an active therapeutic strategy.
Sialic Acid Binding in Cancer
Tumor cells often display altered sialylation that engages inhibitory Siglecs on immune cells, promoting immune evasion. Siglec-15 and Siglec-10 are considered immune checkpoint molecules, and blockade of sialic acid binding can enhance anti-tumor immunity. Understanding the structural basis of sialic acid binding aids in designing inhibitors.
Sialic Acid Binding in Infectious Diseases
Many pathogens exploit sialic acid binding for host attachment and invasion. Influenza viruses bind sialic acids via hemagglutinin, and the type of sialic acid linkage affects host tropism. Bacteria such as viridans group streptococci use sialic acid-binding adhesins, and the identity of sialic acid modulates infection. Toxoplasma gondii uses SABP1 for host cell invasion.
Sialic Acid Binding in Neurodegeneration
In the nervous system, sialic acid-binding proteins like MAG and Siglec-11 are involved in neuronal regeneration and neuroinflammation. Dysregulation of sialic acid binding contributes to neurodegenerative conditions such as Alzheimer's disease and multiple sclerosis.
From sialic acid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of Siglec-7 alter sialic acid binding specificity? | CRISPR knockout of SIGLEC7 in NK cells |
| Can a point mutation in the sialic acid-binding site abolish ligand recognition? | CRISPR point mutation knock-in in SIGLEC7 |
| Does overexpression of Siglec-10 enhance immune evasion? | CRISPR overexpression in cancer cell lines |
| How does sialic acid identity affect bacterial adhesion? | Knockout of bacterial adhesin genes; glycan arrays |
| What is the role of SABP1 in Toxoplasma invasion? | CRISPR knockout of SABP1 in T. gondii |
| Does sialic acid binding regulate B cell tolerance? | Knock-in of signaling-deficient CD22 mutants |
How to Study the sialic acid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Glycan array | Binding specificity to diverse sialosides | Profiling Siglec ligands |
| Surface plasmon resonance | Binding affinity and kinetics | Quantifying sialic acid-protein interactions |
| CRISPR knockout screen | Genes required for sialic acid binding | Identifying regulators of immune evasion |
| X-ray crystallography | 3D structure of binding site | Structural basis of Siglec-7 binding |
| Flow cytometry | Cell surface sialic acid levels | Immune cell phenotyping |
| Fluorescence microscopy | Localization of sialic acid-binding proteins | Host-pathogen interaction studies |
| Sialidase treatment assay | Dependence on sialic acid for binding | Validating sialic acid specificity |
Glycan Arrays and Binding Assays
Glycan arrays present diverse sialic acid-containing oligosaccharides to probe binding specificity of sialic acid-binding proteins. Surface plasmon resonance and isothermal titration calorimetry provide quantitative binding affinities. These methods are essential for characterizing Siglec-ligand interactions.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout screens can identify genes required for sialic acid binding and downstream signaling. Focused screens targeting glycosylation enzymes reveal regulators of ligand display. These approaches link genotype to sialic acid-binding phenotypes.
Structural Biology and Modeling
X-ray crystallography and cryo-EM have elucidated the sialic acid-binding site of Siglec-7 and other lectins. Molecular dynamics simulations complement structural studies to understand binding dynamics. These methods guide rational design of inhibitors.
Flow Cytometry and Imaging
Flow cytometry with sialic acid-specific lectins or antibodies measures cell surface sialylation and binding. Fluorescence microscopy visualizes sialic acid-binding protein localization and interactions. These techniques are widely used in immunology and microbiology.
How CRISPR Can Be Used to Study GO:0033691 sialic acid binding
Knockout
CRISPR knockout of genes encoding sialic acid-binding proteins (e.g., SIGLEC7, SIGLEC10) ablates binding and allows assessment of downstream functions in immune cells. Knockout of pathogen adhesins (e.g., SABP1) reduces host cell attachment and invasion.
Point Mutation
CRISPR point mutation can introduce specific amino acid substitutions in the sialic acid-binding pocket to dissect the contribution of individual residues to ligand recognition. Such models are valuable for separating binding from signaling functions.
Knock-in
Knock-in of tagged or mutant sialic acid-binding proteins enables tracking and functional analysis in primary cells. Knock-in of human Siglecs into mouse models can humanize sialic acid recognition for in vivo studies.
Overexpression
CRISPR-mediated overexpression of sialic acid-binding proteins (e.g., Siglec-15) in cancer cells can model immune evasion and test therapeutic blockade. Overexpression in cell lines facilitates biochemical characterization of binding.
How EDITGENE Supports sialic acid binding Research
Researchers studying sialic acid binding-related genes often need to determine whether a candidate gene is causally involved in ligand recognition, immune regulation, or pathogen attachment. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for sialic acid binding research.
Frequently Asked Questions About sialic acid binding
What is sialic acid binding?
Sialic acid binding (GO:0033691) is a molecular function defined as binding to a sialic acid, a nine-carbon monosaccharide derivative of neuraminic acid, often found on glycoproteins and glycolipids.
What genes are involved in sialic acid binding?
Key genes include SIGLEC family members (e.g., SIGLEC1, SIGLEC7, SIGLEC9, SIGLEC10, SIGLEC15), CD22, MAG, and pathogen genes like SABP1 and influenza hemagglutinin.
What is the function of sialic acid binding in the immune system?
Sialic acid binding by Siglecs regulates immune cell activation and inhibition, contributing to self-recognition and tolerance.
How do pathogens use sialic acid binding?
Viruses, bacteria, and parasites use sialic acid-binding proteins to attach to host cells and initiate infection.
What diseases are associated with sialic acid binding?
Dysregulation is linked to autoimmune diseases, cancer, neurodegeneration, and infectious diseases.
What is the GO ID for sialic acid binding?
The GO ID is GO:0033691, under the molecular_function ontology.
What are Siglecs?
Siglecs are sialic acid-binding immunoglobulin-like lectins expressed on immune cells that mediate sialic acid recognition and signaling.
How can I study sialic acid binding using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of sialic acid-binding proteins in cells and pathogens.
What methods are used to measure sialic acid binding?
Common methods include glycan arrays, surface plasmon resonance, flow cytometry, and structural biology techniques.
Why is sialic acid binding important for drug development?
It is a target for cancer immunotherapy, anti-inflammatory drugs, and antiviral agents, as it controls immune evasion and pathogen entry.
Conclusion
Sialic acid binding (GO:0033691) is a pivotal molecular function that underlies immune regulation, host-pathogen interactions, and disease pathogenesis. The Siglec family and pathogen-derived sialic acid-binding proteins are key mediators, and their study has revealed therapeutic opportunities in cancer, autoimmunity, and infectious diseases. Advances in CRISPR genome editing and glycan analysis continue to illuminate the mechanisms and regulation of sialic acid binding, offering new avenues for intervention.
References
- 1. Morishita S et al.. 2026. New Sialic Acid-Binding Site of SIGLEC-7.. Adv Exp Med Biol 1491:91-107 PMID: 41917391
- 2. Munday J et al.. 1999. Sialic acid binding receptors (siglecs) expressed by macrophages.. J Leukoc Biol 66(5):705-11 PMID: 10577497
- 3. Siddiqui SS. 2023. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.. Mol Aspects Med 90:101145 PMID: 36153172
- 4. Morrison KM et al.. 2025. Sialic acid identity modulates host tropism of sialoglycan-binding viridans group streptococci.. J Biol Chem 301(9):110540 PMID: 40749830
- 5. Wasik BR et al.. 2016. Effects of Sialic Acid Modifications on Virus Binding and Infection.. Trends Microbiol 24(12):991-1001 PMID: 27491885
- 6. Macauley MS et al.. 2014. Siglec-mediated regulation of immune cell function in disease.. Nat Rev Immunol 14(10):653-66 PMID: 25234143
- 7. Xing M et al.. 2020. A Sialic Acid-Binding Protein SABP1 of Toxoplasma gondii Mediates Host Cell Attachment and Invasion.. J Infect Dis 222(1):126-135 PMID: 32060530
- 8. Crocker PR et al.. 2007. Siglecs and their roles in the immune system.. Nat Rev Immunol 7(4):255-66 PMID: 17380156
